SMIT yields 13333.33% · JNJ yields 2.14%● Live data
📍 SMIT pulled ahead of the other in Year 1
Combined, SMIT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMIT + JNJ for your $10,000?
Schmitt Industries, Inc., together with its subsidiaries, designs, manufactures, and sells test and measurement products worldwide. The company operates through two segments, Measurement and Ice Cream. The Measurement segment designs, manufactures, and sells laser and confocal chromatic white light sensors for distance measurement and dimensional sizing products under the Acuity brand name for various industrial applications, including manufacturing, lumber production, steel casting, glass and paper production, medical imaging, crane control and micron-level part, and surface inspection. It also offers AR550 high speed laser sensor for application in vibration measurements, scanning of roads, vehicle crash tests, and ballistic measurements; AS2100, an accurate distance sensor, used in metal production, transportation industry, process control, and fill level measurement applications; and satellite focused remote tank monitoring products under the Xact brand that measure the fill levels of tanks holding propane, diesel, and other tank-based liquids, as well as related monitoring services, including transmission of fill data from the tanks via satellite to a secure website for display. The Ice Cream segment manufactures, wholesales, and retails ice creams and ice cream cakes, as well as sells through its website; and serves ice cream at catering events and holds various community-building events comprising ice cream classes, and live comedy and music performances through Ample Hills Creamery brand. Schmitt Industries, Inc. was founded in 1984 and is headquartered in Portland, Oregon.
Full SMIT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.